Baroda BNP Paribas Health and Wellness Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 9.5339 ↓ -0.12%
[as on 26 December, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth- -0.12% 0.38% -2.06% 0.23%-----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
95.53% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 4.47%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology9.25%340000-17.07%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology7.29%190000-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.05%65025-21.18%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.18%50000-
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.54%300000-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.38%222500-
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services4.91%450000+12.50%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology4.57%9800+8.89%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology4.00%26000+15.56%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.73%120000+33.33%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology3.73%65000-
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology3.06%510000-
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.95%74350-
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services2.87%130000+18.18%
ICICI Prudential Life Insurance Company LimitedICICIPRULI (INE726G01019)Insurance2.76%290000-
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.71%100000-
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.65%129582-
Natco Pharma LimitedNATCOPHARM (INE987B01026)Pharmaceuticals & Biotechnology2.64%200000-
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology2.43%200000-
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies2.41%75000-
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%40000+100.00%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology1.93%100000-
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology1.90%60000-
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.65%100000-
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing1.41%115000-
Jupiter Life Line Hospitals LimitedJLHL (INE682M01012)Healthcare Services0.51%20000-
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

Baroda BNP Paribas Health and Wellness Fund Direct Growth - 30 days NAV history

DateNAV
26 December, 20259.5339
24 December, 20259.5457
23 December, 20259.5546
22 December, 20259.5522
19 December, 20259.4978
18 December, 20259.4123
17 December, 20259.4019
16 December, 20259.4426
15 December, 20259.5207
12 December, 20259.5738
11 December, 20259.5590
10 December, 20259.5133
9 December, 20259.5098
8 December, 20259.5326
5 December, 20259.6564
4 December, 20259.6596
3 December, 20259.6379
2 December, 20259.6671
1 December, 20259.6772
28 November, 20259.7403
27 November, 20259.7061
26 November, 20259.7345
25 November, 20259.6509
24 November, 20259.6370
21 November, 20259.6505
20 November, 20259.6932
19 November, 20259.6908
18 November, 20259.6691
17 November, 20259.7432
14 November, 20259.7318

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Baroda BNP Paribas Health and Wellness Fund Direct Growth?
    The latest NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth is 9.5339 as on 26 December, 2025.